DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ATELVIA
02 1DICLOFENAC SODIUM
03 2DIVALPROEX SODIUM
04 2ESOMEPRAZOLE MAGNESIUM
05 1NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
06 2OMEPRAZOLE MAGNESIUM
07 1PANTOPRAZOLE SODIUM
08 1PRILOSEC OTC
09 1PROTONIX
10 1RABEPRAZOLE SODIUM
11 1RISEDRONATE SODIUM
12 1VIMOVO
13 1YOSPRALA
01 120987
02 121229
03 122511
04 122560
05 174514
06 176885
07 177296
08 190062
09 1202882
10 1203217
11 1204152
12 1204920
13 1205103
14 1206877
15 1209202
16 1211571
01 14No
02 2Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 211571
Country : US
Patented : No
Drug : DICLOFENAC SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 74514
Country : US
Patented : No
Drug : ATELVIA
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 22560
Country : US
Patented : Yes
Drug : PRILOSEC OTC
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 21229
Country : US
Patented : No
Drug : OMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 206877
Country : US
Patented : No
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 77296
Country : US
Patented : No
Drug : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 202882
Country : US
Patented : No
Drug : OMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204152
Country : US
Patented : No
Drug : RISEDRONATE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 203217
Country : US
Patented : No
Drug : PROTONIX
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 20987
Country : US
Patented : No
